查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830887

2025年核糖核酸（RNA）編輯全球市場報告

Ribonucleic Acid (RNA) Editing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，核糖核酸 (RNA) 編輯市場規模強勁成長，從 2024 年的 161 億美元成長至 2025 年的 175.5 億美元，複合年成長率為 9.0%。預測期內的成長動力包括：對瞬時和可逆 RNA 編輯方法的需求不斷成長、其在神經退化性疾病研究中的應用不斷拓展、罕見疾病和孤兒病患病率的上升、人們對合成生物學和生物技術的興趣日益濃厚，以及學術和轉化研究活動的不斷活躍。

預計未來幾年核糖核酸 (RNA) 編輯市場規模將強勁成長，到 2029 年將達到 244.2 億美元，複合年成長率為 8.6%。預測期內的成長可歸因於遺傳疾病盛行率的上升、對個人化醫療的日益關注、癌症治療應用的增多、遞送系統的進步以及政府和監管機構日益增強的支持。這段時期的主要趨勢包括 RNA 編輯平台的創新、體內遞送技術的進步、定序和轉錄組學的進展、瞬時基因調控技術的發展以及合成生物學應用的不斷拓展。

核糖核酸 (RNA) 編輯是一種轉錄後機制，它改變去氧核糖核酸(DNA) 轉錄成 RNA 分子後的鹼基序列。這些修飾可以改變所生成蛋白質的結構和功能，進而影響基因表現並帶來治療潛力。

RNA編輯的主要類型包括傳訊RNA(mRNA)修飾、轉移RNA (tRNA)修飾和核醣體RNA (rRNA)修飾。傳訊RNA修飾涉及轉錄後mRNA分子的化學變化，例如甲基化和核苷酸序列的改變。常見的修飾方式包括核苷酸插入、缺失和脫氨基。這些修飾已被應用於癌症、遺傳性疾病和短暫性疾病的治療。

2025年春季美國關稅的突然上調及其引發的貿易摩擦正對製藥公司造成嚴重衝擊。高利潤率的學名藥製造商尤其容易受到影響，一些公司正在縮減低收益藥品的生產。由於關稅導致的專用試劑短缺，生物技術公司正面臨臨床試驗延遲。為此，該產業正在印度和歐洲擴大原料藥的生產，增加庫存，並遊說獲得基本藥物的貿易豁免。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供核糖核酸（RNA 編輯）市場統計數據，例如全球市場規模、區域佔有率、競爭對手的核糖核酸（RNA 編輯）市場佔有率、詳細的核糖核酸（RNA 編輯）細分市場、市場趨勢和機遇，以及在核糖核酸（RNA 編輯）市場取得成功所需的數據。本核糖核酸（RNA 編輯）市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切資訊的完整觀點。

遺傳疾病的盛行率不斷上升，推動了核糖核酸 (RNA) 編輯市場的成長。由遺傳或自發性突變引起的遺傳疾病正變得越來越普遍，部分原因是父母年齡的成長增加了染色體異常的可能性。 RNA 編輯可以透過在 RNA 層面上糾正突變來實現治療，使細胞能夠在不改變底層 DNA 的情況下產生功能性蛋白質。例如，截至 2024 年 5 月，美國約有 10 萬人患有鐮狀細胞疾病，這表明對基於 RNA 的治療方法的需求很高。

RNA編輯市場中的公司正在推進創新方法，例如體內基因編輯，它直接修改活細胞內的基因以糾正致病突變。 2024年4月，雷特氏症研究信託基金推出了MECP2編輯聯盟，旨在開發針對雷特氏症遺傳病因的RNA和DNA編輯療法。該聯盟匯集了六家領先研究機構的專業知識，旨在加速這種神經系統疾病精準且可能治癒的治療方法的臨床開發。

2025年5月，韓國生物製藥公司Rznomics Inc.與禮來公司合作，開發一種用於治療感音性聽障的RNA編輯療法。 Rznomics將利用其反式剪接核酶平台進行早期研究，而禮來公司則負責後期開發和全球商業化。此次合作凸顯了對RNA編輯技術的持續投資，旨在為遺傳疾病和罕見疾病提供標靶治療。

核糖核酸 (RNA) 編輯市場由提供治療性核糖核酸 (RNA) 編輯服務、核糖核酸 (RNA) 編輯遞送最佳化、生物資訊學和數據分析服務的營業單位所獲得的收益組成。市場價值還包括服務提供者銷售的或包含在其服務產品中的相關產品的價值。核糖核酸 (RNA) 編輯市場還包括核糖核酸 (RNA) 編輯療法、診斷套件和核糖核酸 (RNA) 編輯遞送系統的銷售。這是產品製造商或創造者向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品的價值。該市場中的產品價值還包括產品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球核糖核酸（RNA 編譯）市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球核糖核酸（RNA）編輯市場：成長率分析
  • 全球核糖核酸 (RNA) 編輯市場表現：規模與成長，2019-2024 年
  • 全球核糖核酸 (RNA) 編輯市場預測：規模與成長，2024-2029 年，2034 年
  • 全球核糖核酸 (RNA) 編輯：總目標市場 (TAM)

第6章 市場細分

  • 全球核糖核酸 (RNA) 編輯市場：按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 信使核糖核酸（RNA）修飾
  • 轉移核糖核酸（RNA）修飾
  • 核醣體核糖核酸（RNA）的修飾
  • 全球核糖核酸 (RNA) 編輯市場：按技術、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 插入或刪除
  • 脫氨
  • 全球核糖核酸 (RNA) 編輯市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 癌症
  • 遺傳性疾病
  • 暫時疾病
  • 全球核糖核酸 (RNA) 編輯市場：依信使核糖核酸 (RNA) (mRNA) 修飾細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 鹼基編輯
  • 參與核糖核酸（RNA）介導的編輯的Adenosine deaminase
  • 定點核糖核酸（RNA）編輯
  • 全球核糖核酸 (RNA) 編輯市場：按轉移核糖核酸 (RNA) (Trna) 修飾細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 假尿苷化
  • 轉移RNA剪接
  • 肌苷修飾
  • 全球核糖核酸 (RNA) 編輯市場：細分：核醣體核糖核酸 (RNA) (RRNA) 修飾（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 假尿苷化
  • 核醣體RNA成熟途徑的調控
  • 位點特異性核醣體核糖核酸（RNA）編輯

第7章 區域和國家分析

  • 全球核糖核酸 (RNA) 編輯市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球核糖核酸 (RNA) 編輯市場：按國家/地區、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 核糖核酸（RNA）編輯市場：競爭格局
  • 核糖核酸（RNA）編輯市場：公司簡介
    • Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Arcturus Therapeutics Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • CureVac AG Overview, Products and Services, Strategy and Financial Analysis
    • Beam Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • EdiGene Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Ethris GmbH
  • Deep Genomics Incorporated
  • ProQR Therapeutics NV
  • ReCode Therapeutics
  • Capstan Therapeutics Inc.
  • TriLink BioTechnologies
  • ADARx Pharmaceuticals Inc.
  • Storm Therapeutics Limited
  • Ascidian Therapeutics Inc.
  • Rznomics Inc.
  • Airna Biotech SL
  • hC Bioscience Inc.
  • Korro Bio Inc.
  • Shape TX
  • Turn Biotechnologies

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年核糖核酸（RNA編輯）市場：提供新機會的國家
  • 2029年核糖核酸（RNA編輯）市場：細分領域帶來新機會
  • 核糖核酸（RNA）編輯市場2029年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r37878

Ribonucleic acid (RNA) editing is a post-transcriptional mechanism that modifies the nucleotide sequence of RNA molecules after they are transcribed from deoxyribonucleic acid (DNA). These modifications can alter the structure or function of the resulting protein, thereby influencing gene expression and presenting potential therapeutic opportunities.

The primary types of RNA editing include messenger RNA (mRNA) modification, transfer RNA (tRNA) modification, and ribosomal RNA (rRNA) modification. Messenger RNA modification involves chemical alterations to mRNA molecules after transcription, such as methylation or nucleotide sequence changes. Common techniques include nucleotide insertion or deletion and deamination. These modifications have applications in treating conditions such as cancer, genetic disorders, and transient ailments.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The ribonucleic acid (RNA) editing market research report is one of a series of new reports from The Business Research Company that provides ribonucleic acid (RNA) editing market statistics, including the ribonucleic acid (RNA) editing industry's global market size, regional shares, competitors with the ribonucleic acid (RNA) editing market share, detailed ribonucleic acid (RNA) editing market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (RNA) editing market. This ribonucleic acid (RNA) editing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The ribonucleic acid (RNA) editing market size has grown strongly in recent years. It will grow from $16.10 billion in 2024 to $17.55 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to the rising demand for transient and reversible RNA editing methods, expanding applications in neurodegenerative disease research, increasing prevalence of rare and orphan diseases, growing interest in synthetic biology and bioengineering, and heightened academic and translational research activities.

The ribonucleic acid (RNA) editing market size is expected to see strong growth in the next few years. It will grow to $24.42 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to the rising prevalence of genetic disorders, expanding emphasis on personalized medicine, increasing applications in cancer therapy, advancements in delivery systems, and growing support from government and regulatory agencies. Major trends during this period include innovations in RNA editing platforms, progress in in vivo delivery technologies, advancements in sequencing and transcriptomics, development of transient gene modulation techniques, and expansion of synthetic biology applications.

The rising prevalence of genetic disorders is driving growth in the ribonucleic acid (RNA) editing market. Genetic disorders, caused by inherited or spontaneous mutations, are becoming more common partly due to increasing parental age, which raises the likelihood of chromosomal abnormalities. RNA editing enables treatment by correcting mutations at the RNA level, allowing cells to produce functional proteins without changing the underlying DNA. For example, as of May 2024, sickle cell disease affects approximately 100,000 people in the United States, illustrating the significant need for RNA-based therapeutic approaches.

Companies in the RNA editing market are advancing innovative approaches such as in vivo gene editing, which directly alters genes within living cells to correct disease-causing mutations. In April 2024, the Rett Syndrome Research Trust launched the MECP2 Editing Consortium to develop RNA and DNA editing therapies targeting the genetic causes of Rett syndrome. By combining expertise from six leading laboratories, the consortium aims to accelerate clinical development of precise, potentially curative treatments for this neurological disorder.

In May 2025, Rznomics Inc., a South Korea-based biopharmaceutical company, partnered with Eli Lilly and Company to develop RNA-editing therapies for sensorineural hearing loss. Rznomics is utilizing its trans-splicing ribozyme platform for early-stage research, while Eli Lilly manages later-stage development and global commercialization. This collaboration highlights the growing investment in RNA-editing technologies to deliver targeted therapies for genetic and rare diseases.

Major players in the ribonucleic acid (RNA) editing market are Moderna Inc., Arcturus Therapeutics Holdings Inc., CureVac AG, Beam Therapeutics Inc., EdiGene Inc., Ethris GmbH, Deep Genomics Incorporated, ProQR Therapeutics NV, ReCode Therapeutics, Capstan Therapeutics Inc., TriLink BioTechnologies, ADARx Pharmaceuticals Inc., Storm Therapeutics Limited, Ascidian Therapeutics Inc., Rznomics Inc., Airna Biotech S.L., hC Bioscience Inc., Korro Bio Inc., Shape TX, and Turn Biotechnologies.

North America was the largest region in the ribonucleic acid(RNA) editing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ribonucleic acid (RNA) editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ribonucleic acid (RNA) editing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ribonucleic acid (RNA) editing market consists of revenues earned by entities by providing services such as therapeutic ribonucleic acid (RNA) editing services, ribonucleic acid (RNA) editing delivery optimization, and bioinformatics and data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The ribonucleic acid (RNA) editing market also includes sales of ribonucleic acid (RNA) editing therapeutics, diagnostic kits, and ribonucleic acid (RNA) editing delivery systems. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ribonucleic Acid (RNA) Editing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ribonucleic acid (rna) editing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ribonucleic acid (rna) editing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ribonucleic acid (rna) editing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Messenger Ribonucleic Acid (RNA) Modification; Transfer Ribonucleic Acid (RNA) Modification; Ribosomal Ribonucleic Acid (RNA) Modification
  • 2) By Technique: Insertion Or Deletion; Deamination
  • 3) By Application: Cancer; Genetic Disorders; Temporary Maladies
  • Subsegments:
  • 1) By Messenger Ribonucleic Acid(RNA) (Mrna) Modification: Base Editing; Adenosine Deaminase Acting On Ribonucleic Acid (RNA)-Mediated Editing; Site-Directed Ribonucleic Acid (RNA) Editing
  • 2) By Transfer Ribonucleic Acid (RNA) (Trna) Modification: Pseudouridylation; Transfer Ribonucleic Acid Splicing; Inosine Modification
  • 3) By Ribosomal Ribonucleic Acid (RNA) (Rrna) Modification: Pseudouridylation; Ribosomal Ribonucleic Acid (RNA) Maturation Pathway Modulation; Site-Specific Ribosomal Ribonucleic Acid (RNA) Editing
  • Companies Mentioned: Moderna Inc.; Arcturus Therapeutics Holdings Inc.; CureVac AG; Beam Therapeutics Inc.; EdiGene Inc.; Ethris GmbH; Deep Genomics Incorporated; ProQR Therapeutics NV; ReCode Therapeutics; Capstan Therapeutics Inc.; TriLink BioTechnologies; ADARx Pharmaceuticals Inc.; Storm Therapeutics Limited; Ascidian Therapeutics Inc.; Rznomics Inc.; Airna Biotech S.L.; hC Bioscience Inc.; Korro Bio Inc.; Shape TX; Turn Biotechnologies.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ribonucleic Acid (RNA) Editing Market Characteristics

3. Ribonucleic Acid (RNA) Editing Market Trends And Strategies

4. Ribonucleic Acid (RNA) Editing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Ribonucleic Acid (RNA) Editing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Ribonucleic Acid (RNA) Editing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Ribonucleic Acid (RNA) Editing Market Growth Rate Analysis
  • 5.4. Global Ribonucleic Acid (RNA) Editing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Ribonucleic Acid (RNA) Editing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Ribonucleic Acid (RNA) Editing Total Addressable Market (TAM)

6. Ribonucleic Acid (RNA) Editing Market Segmentation

  • 6.1. Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Messenger Ribonucleic Acid(RNA) Modification
  • Transfer Ribonucleic Acid(RNA) Modification
  • Ribosomal Ribonucleic Acid(RNA) Modification
  • 6.2. Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Insertion Or Deletion
  • Deamination
  • 6.3. Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer
  • Genetic Disorders
  • Temporary Maladies
  • 6.4. Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Messenger Ribonucleic Acid(RNA) (Mrna) Modification, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Base Editing
  • Adenosine Deaminase Acting On Ribonucleic Acid(RNA)-Mediated Editing
  • Site-Directed Ribonucleic Acid (RNA) Editing
  • 6.5. Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Transfer Ribonucleic Acid(RNA) (Trna) Modification, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pseudouridylation
  • Transfer Ribonucleic Acid Splicing
  • Inosine Modification
  • 6.6. Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Ribosomal Ribonucleic Acid(RNA) (Rrna) Modification, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pseudouridylation
  • Ribosomal Ribonucleic Acid(RNA) Maturation Pathway Modulation
  • Site-Specific Ribosomal Ribonucleic Acid (RNA) Editing

7. Ribonucleic Acid (RNA) Editing Market Regional And Country Analysis

  • 7.1. Global Ribonucleic Acid (RNA) Editing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Ribonucleic Acid (RNA) Editing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ribonucleic Acid (RNA) Editing Market

  • 8.1. Asia-Pacific Ribonucleic Acid (RNA) Editing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ribonucleic Acid (RNA) Editing Market

  • 9.1. China Ribonucleic Acid (RNA) Editing Market Overview
  • 9.2. China Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ribonucleic Acid (RNA) Editing Market

  • 10.1. India Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ribonucleic Acid (RNA) Editing Market

  • 11.1. Japan Ribonucleic Acid (RNA) Editing Market Overview
  • 11.2. Japan Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ribonucleic Acid (RNA) Editing Market

  • 12.1. Australia Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ribonucleic Acid (RNA) Editing Market

  • 13.1. Indonesia Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ribonucleic Acid (RNA) Editing Market

  • 14.1. South Korea Ribonucleic Acid (RNA) Editing Market Overview
  • 14.2. South Korea Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ribonucleic Acid (RNA) Editing Market

  • 15.1. Western Europe Ribonucleic Acid (RNA) Editing Market Overview
  • 15.2. Western Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ribonucleic Acid (RNA) Editing Market

  • 16.1. UK Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ribonucleic Acid (RNA) Editing Market

  • 17.1. Germany Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ribonucleic Acid (RNA) Editing Market

  • 18.1. France Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ribonucleic Acid (RNA) Editing Market

  • 19.1. Italy Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ribonucleic Acid (RNA) Editing Market

  • 20.1. Spain Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ribonucleic Acid (RNA) Editing Market

  • 21.1. Eastern Europe Ribonucleic Acid (RNA) Editing Market Overview
  • 21.2. Eastern Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ribonucleic Acid (RNA) Editing Market

  • 22.1. Russia Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ribonucleic Acid (RNA) Editing Market

  • 23.1. North America Ribonucleic Acid (RNA) Editing Market Overview
  • 23.2. North America Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ribonucleic Acid (RNA) Editing Market

  • 24.1. USA Ribonucleic Acid (RNA) Editing Market Overview
  • 24.2. USA Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ribonucleic Acid (RNA) Editing Market

  • 25.1. Canada Ribonucleic Acid (RNA) Editing Market Overview
  • 25.2. Canada Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ribonucleic Acid (RNA) Editing Market

  • 26.1. South America Ribonucleic Acid (RNA) Editing Market Overview
  • 26.2. South America Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ribonucleic Acid (RNA) Editing Market

  • 27.1. Brazil Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ribonucleic Acid (RNA) Editing Market

  • 28.1. Middle East Ribonucleic Acid (RNA) Editing Market Overview
  • 28.2. Middle East Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ribonucleic Acid (RNA) Editing Market

  • 29.1. Africa Ribonucleic Acid (RNA) Editing Market Overview
  • 29.2. Africa Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ribonucleic Acid (RNA) Editing Market Competitive Landscape And Company Profiles

  • 30.1. Ribonucleic Acid (RNA) Editing Market Competitive Landscape
  • 30.2. Ribonucleic Acid (RNA) Editing Market Company Profiles
    • 30.2.1. Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Arcturus Therapeutics Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. CureVac AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Beam Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. EdiGene Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Ribonucleic Acid (RNA) Editing Market Other Major And Innovative Companies

  • 31.1. Ethris GmbH
  • 31.2. Deep Genomics Incorporated
  • 31.3. ProQR Therapeutics NV
  • 31.4. ReCode Therapeutics
  • 31.5. Capstan Therapeutics Inc.
  • 31.6. TriLink BioTechnologies
  • 31.7. ADARx Pharmaceuticals Inc.
  • 31.8. Storm Therapeutics Limited
  • 31.9. Ascidian Therapeutics Inc.
  • 31.10. Rznomics Inc.
  • 31.11. Airna Biotech S.L.
  • 31.12. hC Bioscience Inc.
  • 31.13. Korro Bio Inc.
  • 31.14. Shape TX
  • 31.15. Turn Biotechnologies

32. Global Ribonucleic Acid (RNA) Editing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ribonucleic Acid (RNA) Editing Market

34. Recent Developments In The Ribonucleic Acid (RNA) Editing Market

35. Ribonucleic Acid (RNA) Editing Market High Potential Countries, Segments and Strategies

  • 35.1 Ribonucleic Acid (RNA) Editing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Ribonucleic Acid (RNA) Editing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Ribonucleic Acid (RNA) Editing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer